Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NTRA - Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading Value


NTRA - Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading Value

  • Natera, Inc. is a leading global diagnostics company developing cell-free DNA ("cfDNA") tests focusing on women's health, oncology, and organ health.
  • Natera's current diagnostics product offering includes ~10 different unique tests with most of the product revenues coming from the sale of the Panorama and HCS tests.
  • Natera is in a strong financial position as of 1Q 2021 with 2-3 years of funding based on cash of $654M and a TTM cash burn of -$244M.
  • Natera has maintained strong revenue growth in 2020 reaching $391M (+29% y/y) driven by sales of Panorama and HCS tests with management guidance for 2021's revenues expected to reach ~$562.5M (+44% y/y).
  • In summary, the author projects Natera, Inc. as a "buy" at a 2-year Wall Street price target of $137 (+21% upside).

For further details see:

Natera: Leading cfDNA Diagnostics Company Offers Strong Growth And Fair Trading Value
Stock Information

Company Name: Natera Inc.
Stock Symbol: NTRA
Market: NASDAQ
Website: natera.com

Menu

NTRA NTRA Quote NTRA Short NTRA News NTRA Articles NTRA Message Board
Get NTRA Alerts

News, Short Squeeze, Breakout and More Instantly...